Uses of Songtaisi

Songtaisi is a drug containing the main ingredient Glutathione, which is used to improve metabolism and metabolism, helping to remove toxic exogenous substances.

Songtaisi contains the main ingredient Reduced Glutathione and is formulated as Reduced Glutathione sodium. Glutathione is intrinsically an endogenous tripeptide and is present in all cells of organs and body systems. This wide distribution is related to the wide range of biological functions of Glutathione, the most prominent of which are important roles in many biochemical and metabolic processes.
In Glutathione contains sulfridilic group of cysteine ​​which is very nucleophilic and easily reacts with chemical substances or other metabolites by electrophilic mechanism, thereby inactivating exogenous substances. can be toxic.
Therefore, Glutathione is often used in the treatment of poisoning cases related to situations such as hepatotoxicity due to ethyl alcohol or drugs, specific chemotherapeutic agents...

Songtaisi is indicated for use in the following cases:
Reduces neurotoxicity in patients undergoing radiation and chemotherapy with cancer chemotherapy agents, including Cisplatin, 5 -fiuorouracil, Cyclophosphamide, Oxaplatin, Carboplatin by intravenous injection of Glutathione just before radiotherapy and before performing chemotherapy regimens of the above chemicals. Treatment of cases of mercury poisoning by combining infusion of Glutathione and high doses of vitamin C with specific drugs to treat mercury poisoning such as meso-2,3-dimercaptosuccinic acid and 2,3-dimercaptoprnpan-l- sulphate/onate to lower blood mercury levels. Support in the treatment of cases of alcoholic cirrhosis, hepatitis caused by viruses B, C, D and fatty liver to improve the patient's condition as well as liver function indicators (bilirubin, GOT, GPT, GT) or decreased MDA and marked hepatocellular damage. Aids in the treatment of peripheral, coronary and other hematological disorders by improving the hemodynamic parameters of the major and minor circulatory systems to prolong pain-free walking time. in patients with lower extremity artery occlusion. At the same time, the drug has the ability to improve the vasomotor response to coronary vasodilators such as Acetylcholine, Nitroglycerin in patients at risk of coronary heart disease. Improves symptoms in patients with subarachnoid hemorrhage Increases insulin sensitivity in patients with diabetes.

The drug can be administered intravenously or intramuscularly.
Using intravenous line: Treatment to reduce neurotoxicity in patients undergoing radiotherapy and chemotherapy: Songtaisi 1200 mg slow intravenous infusion right before radiotherapy 15 minutes. Songtaisi slow intravenous infusion 1500mg - 2400mg in 15 minutes before performing the chemotherapy regimen of chemicals cisplatin, cyclophosphamide, carboplatin, oxaplatin, 5 fluorouracil. Support in the treatment of mercury poisoning with doses of 1200 - 1800mg/day and maintain Songtaisi 600mg/day until recovery. Support in the treatment of alcoholic cirrhosis or viral hepatitis: Treatment of alcoholic cirrhosis is 600 mg - 1200 mg/day by slow intravenous injection. Treatment of cirrhosis, hepatitis caused by viruses B, C, D and fatty liver by using Songtaisi 600 mg - 1200 mg/day by slow intravenous injection until recovery. Support treatment in the pathologies of peripheral vascular disorders, coronary and hematological disorders: Peripheral vascular disorders use Songtaisi 600 mg/time, 2 times/day, intravenous infusion. Coronary artery disease: Songtaisi 1200 mg - 3000 mg intravenous infusion. Patients with chronic renal failure requiring dialysis: Infusion of Songtaisi 1200mg/day at the end of each filtration cycle can reduce the dose of erythropoietin by 50%. Support for treatment of subarachnoid hemorrhage by slow intravenous infusion of 600mg of Glutathione immediately after surgery and repeat the above dose every 6 hours for about 14 days or more. Using the intramuscular route:
Used as an adjunct in the treatment of male infertility with a dose of 600mg -1200mg/day and intramuscular injection lasting continuously for 2 months.

Contraindicated to use Songtaisi in cases of patients with hypersensitivity to Glutathione or one of the other ingredients of the drug. Rarely reported side effects include nausea, vomiting, headache and, more seriously, skin rashes. Currently, there is no evidence of the effectiveness of this drug in pregnant and lactating women, so it should not be used in this population. Above is information about uses, dosage and precautions when using Songtaisi medicine. To ensure safety for your health and maximize the effectiveness of your treatment, you need to take Songtaisi exactly as directed by your doctor.